Recombinant
RabMAb

Anti-EFEMP2 antibody [EPR684(2)] (ab125073)

Publishing research using ab125073? Please let us know so that we can cite the reference in this datasheet.

ab125073 has been referenced in 4 publications.

  • Wang T  et al. Fibulin-4 is associated with prognosis of endometrial cancer patients and inhibits cancer cell invasion and metastasis via Wnt/ß-catenin signaling pathway. Oncotarget 8:18991-19012 (2017). ICC ; Human . PubMed: 28177909
  • Zhang D  et al. Fibulin-4 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition via the PI3K/Akt/mTOR pathway. Int J Oncol 50:1513-1530 (2017). WB, IHC-P, ICC/IF ; Human . PubMed: 28339091
  • Chen J  et al. Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas. BMC Cancer 15:91 (2015). IHC . PubMed: 25885889
  • Chen J  et al. Overexpression of fibulin-4 is associated with tumor progression and poor prognosis in patients with cervical carcinoma. Oncol Rep 31:2601-10 (2014). PubMed: 24737201

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

Sign up